Rare Cancer
Rare cancers, such as Merkel cell carcinoma and retinoblastoma, account for a significant portion of cancer diagnoses worldwide. Due to their rarity, these cancers often have limited clinical data, making diagnosis and treatment challenging. Research into rare cancers focuses on understanding genetic mutations and tumour behaviour to develop targeted therapies. Personalized medicine and immunotherapy have shown promise in treating rare cancers, offering patients new hope. Collaboration between cancer research centres and international registries is essential for pooling data and improving treatment protocols.
Related Conference of Rare Cancer
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
September 22-23, 2025
11th International Conference on Infectious and Rare Diseases
Vancouver, Canada
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
May 14-15, 2026
13th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Aix-en-Provence, France
Rare Cancer Conference Speakers
Recommended Sessions
- Advancement in the Diagnosis of Rare Diseases
- Biomarkers for Rare Disease Diagnosis and Treatment
- Biomedical Research
- Challenges of Living with a Rare Disease
- Clinical Case Reports and Case Studies
- Clinical Research on Orphan Drugs
- Different Types of Rare Diseases
- Drug Discovery for Rare Diseases
- Emerging Technologies in Rare Disease Research
- Functional Genomics and Gene Therapy for Rare Diseases
- Genetic Testing and Counselling of Rare Diseases
- Health Economics and Market Access for Orphan Drugs
- Infectious Diseases and Immune Deficiencies
- Introduction and Causes of New Rare Diseases
- Orphan Drugs Potentiality
- Rare Autoimmune Disorders
- Rare Bone Diseases
- Rare Cancer
- Rare Diseases and Orphan Drugs
- Rare Diseases of the Heart and Vessels
- Rare Neurological Disorders
- Rare Nutritional and Metabolic Diseases
- Rare Paediatric Diseases
- Rare Skin Diseases
- Regulatory Considerations for Developing Orphan Drugs
- Treatment and Advanced Therapies for Rare Diseases
- Vaccines and Vaccination for Rare Diseases
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Neuro Infections - Infection Prevention 2025 (UK)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Public Health - STD-HIV AIDS-2025 (USA)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)